Biotech
Inuba Prepares the Leap to North America with the Support of U.S. Capital
In the summer, Inuba closed a $1.6 million (€1.4 million) financing round that was used to create the marketing team. Previously, in February 2020, the month of the company’s birth, Inuba raised $338,000(€300,000). This month, Inuba has received the support of Lanzadera, the start-up accelerator promoted by Mercadona’s president, Juan Roig.
Inuba is looking to gain a foothold in Spain, but first it is focusing on North America. The Valencia-based startup faces 2022 with the aim of opening up the market in the United States. The company, whose main product is iNubaBox, expects the authorization of its technology in this country to be a reality in the next two months. Even so, the company has already begun small-scale distribution of its products.
To this end, the company already has the support of a Florida state fund and plans to open a financing round of at least $10 million. The objective is to start industrial production, as Pablo Calatayud, CEO of Inuba, explained to PlantaDoce.
The technology in question, iNubaBox, is an autonomous measurement booth that digitizes the human body through 3D and obtains more than 300 body metrics that are used to recommend a personalized nutritional and exercise plan based on the needs of each individual.
Read more about Inuba and fidn other important business news with the Born2Invest mobile app.
Inuba closed a $1.6 million (€1.4 million) financing round that served to create the marketing team
iNubaBox monitors the percentage of fat, muscle mass, weight, health indices, metabolic age, and caloric needs. In addition, due to its body thermography system, it can measure the temperature of joints and muscles in order to detect or prevent future injuries and pain.
In addition to this product, the Valencian company also has software linked to the iNubaBox system, which is capable of creating nutrition plans adapted to each user through the use of algorithms. This tool is conveyed through a mobile application, whose use by the user is intended to facilitate the work of health professionals when planning the nutrition of their patients. The application is already available in test mode and is expected to become fully operational in its paid version in April 2021.
Inuba has received the support of Lanzadera, the accelerator promoted by Mercadona’s president, Juan Roig
In the summer, Inuba closed a $1.6 million (€1.4 million) financing round that was used to create the marketing team. Previously, in February 2020, the month of the company’s birth, Inuba raised $338,000(€300,000).
This month, Inuba has received the support of Lanzadera, the start-up accelerator promoted by Mercadona’s president, Juan Roig. This support will not take the form of an economic endowment, but will materialize in the form of different training courses, according to the company.
__
(Featured image by ebroslu via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Crowdfunding2 weeks ago
The Crowdfunding Model Has Allowed 225 Projects To Be Financed So Far This Year in Colombia
-
Business20 hours ago
Gold and the Dow Jones Continue Looking Good
-
Crypto2 weeks ago
Ripple: First Details on the Appeal Process with the Securities and Exchange Commission
-
Biotech1 week ago
Agomab Raises 82.1 Million from Sanofi, Invus and Asabys